Details for 2021842894
Up to date per 24.05.2026
Actions
Details for 2021842894
Granted/Registered
European Patent
24.05.2023 A
11.02.2026 B1
14.07.2020
US
202063051721 P
26.04.2021
US
202163179612 P
C12N 15/85 20060101AFI20240716BHEP
Owner
Abeona Therapeutics Inc.1330 Avenue of the Americas, 33rd Floor New York, New York 10019US
Representative
No representatives present
Inventor
PADEGIMAS, Linas New York, New York 10019US
BARRETT, Brianna New York, New York 10019US
Information about Fees